Friday, June 19, 2026
🇺🇸 FDA

pharma · Hereditary Angioedema · Influenza · BCRX

Biocryst

Biocryst patent portfolio — 72 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
München, DE HQ
1986 Founded
6 Employees
Public company Type
BCRX · NYSE Ticker
Company details
Status
Public
HQ
München, DE
Founded
1986
Employees
6
Programs
37
Drugs
17
Patents
72
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Biocryst patents

72 pharmaceutical patents indexed for Biocryst. 1 expire within 24 months.

Biocryst has 72 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

72 patents

Patent portfolio

Page 2 of 2

  1. US 8163703

    Hepatitis C therapies

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8133870

    Therapeutic furopyrimidines and thienopyrimidines

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7994139

    Antiviral therapeutic agents

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7514410

    Hepatitis C therapies

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7429571

    Therapeutic furopyrimidines and thienopyrimidines

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7045535

    Compounds useful for inhibiting paramyxovirus neuraminidase

    Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6946554

    Process for the preparation of 9-deazaguanine derivatives

    Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6936719

    Biaryl compounds as serine protease inhibitors

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6835326

    Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

    Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6762032

    Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response

    Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6699994

    Biaryl compounds as serine protease inhibitors

    Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6680211

    Fluorescent nanocrystal-embedded microspheres for fluorescence analysis

    Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6660719

    Inhibiting T-Cell proliferation

    Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6656915

    Inhibiting T-cell proliferation

    Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6576155

    Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6576786

    Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6562861

    Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6458799

    Deazaguanine analog, preparation thereof and use thereof

    Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6410594

    Substituted cyclopentane compounds useful as neuraminidase inhibitors

    Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6387923

    Imminoribitol PNP inhibitors, preparation thereof and use thereof

    Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6268350

    Polynucleotides for inhibiting metastasis and tumor cell growth

    Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6245752

    Compositions and methods for tolerization in immune complex-mediated disease progression

    Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6224866

    Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

    Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Biocryst have?

72 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Biocryst patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.